This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Further Reading
Body JJ (2001) Bisphosphonates in the treatment of metastatic breast cancer. J Mammary Gland Biol Neoplasia 6: 477–485.
Body JJ (2000) Tumor Bone Diseases and Osteoporosis in Cancer Patients. New York, Basel: Marcel Dekker Inc.
Body JJ, Bartl R, Burckhardt P, et al. (1998) Current use ofbisphosphonates in oncology. J Clin Oncol 16: 3890–3899.
Hillner BE, Ingle IN, Berenson JR, et al. (2000) American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel. J Clin Onco 118: 1378–1391.
Hortobagyi GN, Theriault RL, Lipton A, et al. (1998) Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. J Clin Onco 116: 2038–2044.
McCloskey EV, MacLennan ICM, Drayson M, Chapman C, Dunn J, Kanis JA (1998) A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma. Br J Haematol 100: 317–325.
Mundy GR (1997) Mechanisms of bone metastasis. Cancer 80: 1546–1556.
Theriault RL, Lipton A, Hortobagyi GN, et al. (1999) Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. J Clin Oncol 17: 846–854.
Rights and permissions
Copyright information
© 2004 Springer-Verlag London
About this chapter
Cite this chapter
Body, JJ. (2004). Tumor Bone Diseases. In: Osteoporosis in Clinical Practice. Springer, London. https://doi.org/10.1007/978-0-85729-402-9_22
Download citation
DOI: https://doi.org/10.1007/978-0-85729-402-9_22
Publisher Name: Springer, London
Print ISBN: 978-1-85233-757-5
Online ISBN: 978-0-85729-402-9
eBook Packages: Springer Book Archive